Azole Resistance Mechanisms in Aspergillus fumigatus

Aspergillus fumigatus is a ubiquitous mould responsible for a spectrum of human diseases ranging from allergic bronchopulmonary aspergillosis to life‐threatening invasive infection. Azole drugs, which target the fungal 14α‐sterol‐demethylase enzyme and disrupt ergosterol biosynthesis, have been the cornerstone of both clinical therapy and agricultural fungicide use. Over the past two decades, clinical failures and environmental surveys have revealed an alarming rise in azole‐resistant A. fumigatus. The principal mechanism involves alterations in the cyp51A gene, notably the TR34/L98H and TR46/Y121F/T289A configurations, which combine promoter tandem repeats with point mutations to elevate enzyme expression and reduce drug binding. Beyond cyp51A, genomic studies have identified auxiliary loci and regulatory networks that modulate cell membrane composition, stress responses and efflux pump activity. Environmental application of triazole fungicides has been implicated in the selection of resistant strains, which can then infect azole‐naïve patients. The interplay of fitness costs, compensatory mutations and clonal expansion shapes the epidemiology of resistance. Understanding these diverse mechanisms is essential for preserving azole efficacy, guiding stewardship in medicine and agriculture, and informing the development of next‐generation antifungal agents.

Research from Nature Portfolio

A comprehensive genomic survey published in 2024 analysed whole‐genome sequences of over 1,000 clinical and environmental A. fumigatus isolates from Japan and international collections. Population genomic clustering revealed six distinct lineages with varied geographic distributions. A genome‐wide association study pinpointed novel resistance‐associated loci beyond cyp51A, implicating genes involved in membrane integrity, transcriptional regulation and secondary metabolite production. This work emphasises that, in addition to well‐characterised tandem repeat mutations, a network of diverse genetic factors underpins azole resistance and facilitates its global dissemination.

Azole Resistance Mechanisms in Aspergillus fumigatus publication trend

The graph below shows the total number of articles in azole resistance mechanisms in aspergillus fumigatus across all publications each year (not limited to Nature Index journals).

Technical terms

Azole: A class of antifungal compounds that inhibit 14α‐sterol‐demethylase, blocking ergosterol synthesis in fungal cell membranes.

Cyp51A: Gene encoding 14α‐sterol‐demethylase; point mutations and promoter alterations here are central to azole resistance.

Tandem repeat (TR): A sequence motif repeated consecutively in the genome; in resistance, TR in the cyp51A promoter enhances gene transcription.

Fitness cost: Reduction in growth rate or competitiveness of a resistant strain relative to susceptible counterparts in the absence of drug pressure.

References

1. Exposure to resistant fungi across working environments and time. The Science of The Total Environment (2024).
2. Genomic diversity of the pathogenic fungus Aspergillus fumigatus in Japan reveals the complex genomic basis of azole resistance. Communications Biology (2024).
3. Early Release - Environmental Hot Spots and Resistance-Associated Application Practices for Azole-Resistant Aspergillus fumigatus, Denmark, 2020–2023 - Volume 30, Number 8—August 2024 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases (2024).
4. Variability in competitive fitness among environmental and clinical azole-resistant Aspergillus fumigatus isolates. mBio (2024).